Solbritt Rantapää‐Dahlqvist
Solbritt Rantapää‐Dahlqvist publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #238,269 of 7,710,434 ranked researchers
- Rank in Sweden
- #2,652 of 71,437
- Works
- 460
- Citations
- 25k
- Citations per work
- 55.3
What does Solbritt Rantapää‐Dahlqvist research?
Solbritt Rantapää‐Dahlqvist's work is mostly in Medicine (51%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23651.2%
- Medicine23651.2%
- Everything else15834.4%
- Life Sciences6614.4%
- 1Rheumatology36% of their works
- 2Immunology10% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Molecular Biology4% of their works
- 6Oncology4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- Spondyloarthritis Studies and Treatments
- Systemic Sclerosis and Related Diseases
- Gout, Hyperuricemia, Uric Acid
- Cytokine Signaling Pathways and Interactions
- Vasculitis and related conditions
Which keywords describe Solbritt Rantapää‐Dahlqvist's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Cardiovascular Risk, Biological Therapy, Rheumatoid Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Fc Receptors.
- Vasculitides
- IL-6
- Uric Acid
- Systemic Sclerosis
- Spondyloarthritis
- Endothelial Dysfunction
- Fc Receptors
- Antiphospholipid Syndrome
- Biological Therapy
- Inflammation
- Autoantibodies
- Cardiovascular Risk
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Therapeutic Antibodies
- Ankylosing Spondylitis
- Fibrosis
- Hyperuricemia
- ANCA-associated
- STAT3
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Autoantibodies4163 topics
- Inflammation2873 topics
- Cardiovascular Risk2632 topics
- Biological Therapy2351 topic
- Rheumatoid Arthritis2351 topic
- Antiphospholipid Syndrome1441 topic
- Systemic Lupus Erythematosus1441 topic
- Fc Receptors681 topic
- Therapeutic Antibodies681 topic
- Endothelial Dysfunction652 topics
- Ankylosing Spondylitis441 topic
- Spondyloarthritis441 topic
- Fibrosis371 topic
- Systemic Sclerosis371 topic
- Hyperuricemia281 topic
- Uric Acid281 topic
- ANCA-associated241 topic
- IL-6241 topic
- STAT3241 topic
- Vasculitides241 topic
Where does Solbritt Rantapää‐Dahlqvist work?
Solbritt Rantapää‐Dahlqvist's main affiliation in the publication record is Umeå University, Sweden.
How many publications and citations does Solbritt Rantapää‐Dahlqvist have?
OpenAlex counts 460 works and 25,439 citations for Solbritt Rantapää‐Dahlqvist, an h-index of 76, ranking #238,269 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Solbritt Rantapää‐Dahlqvist. Posts are plain text and can be reported.